miR-3168 promotes hepatocellular carcinoma progression via downregulating p53.

MLA

Lu, Tingting, et al. “MiR-3168 Promotes Hepatocellular Carcinoma Progression via Downregulating P53.” Carcinogenesis, vol. 43, no. 10, Nov. 2022, pp. 956–68. EBSCOhost, https://doi.org/10.1093/carcin/bgac062.

APA

Lu, T., Han, T., & Zhao, M. (2022). miR-3168 promotes hepatocellular carcinoma progression via downregulating p53. Carcinogenesis, 43(10), 956–968. https://doi.org/10.1093/carcin/bgac062

Chicago

Lu, Tingting, Tao Han, and Mingfang Zhao. 2022. “MiR-3168 Promotes Hepatocellular Carcinoma Progression via Downregulating P53.” Carcinogenesis 43 (10): 956–68. doi:10.1093/carcin/bgac062.